HNF4A expression as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort
- PMID: 28583188
- PMCID: PMC5460322
- DOI: 10.1186/s13000-017-0635-2
HNF4A expression as a potential diagnostic tool to discriminate primary gastric cancer from breast cancer metastasis in a Brazilian cohort
Abstract
Background: Among the many challenges in cancer diagnosis is the early distinction between metastatic cancer and a secondary tumor. This difficulty stems from the lack of markers that offer high sensitivity and specificity and can be easily applied in routine laboratory work. An example of this challenge is distinguishing gastric metastases originating from breast cancer from a gastric primary tumor. Hepatocyte nuclear factor 4 alpha (HNF4A) has been suggested as a potential marker in these cases. The aim of this study was to analyze the expression of HNF4A, estrogen receptor (ER), progesterone receptor (PR) and gross cystic disease fluid protein 15 (GCDFP-15) in a Brazilian cohort.
Methods: We performed immunohistochemistry analysis of HNF4A, ER, PR and GCDFP-15 in 126 patients divided into three cohorts: primary breast cancer, primary gastric cancer and both types of tumors.
Results: Our data confirmed the sensitivity and specificity of the HNF4A marker compared to other currently used clinical markers.
Conclusion: HNF4A alone could be a gold standard marker for distinguishing primary gastric cancer from breast metastasis, thus validating its potential clinical use, especially in populations with high genetic diversity.
Keywords: Biomarker; Breast cancer; Gastric cancer; HNF4A; Metastasis.
Figures

Similar articles
-
Diagnostic utility of the combined use of HNF4A and GATA3 in distinction between primary and metastatic breast and gastric carcinomas.APMIS. 2021 Sep;129(9):548-555. doi: 10.1111/apm.13166. Epub 2021 Jul 6. APMIS. 2021. PMID: 34120367
-
HNF4A immunohistochemistry facilitates distinction between primary and metastatic breast and gastric carcinoma.Virchows Arch. 2014 Jun;464(6):673-9. doi: 10.1007/s00428-014-1574-x. Epub 2014 Apr 8. Virchows Arch. 2014. PMID: 24711169
-
Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.Arch Pathol Lab Med. 2005 Mar;129(3):338-47. doi: 10.5858/2005-129-338-UOIIDP. Arch Pathol Lab Med. 2005. PMID: 15737028
-
Breast metastasis of gastric signet-ring cell carcinoma: a case report and literature review.World J Surg Oncol. 2015 Mar 26;13:120. doi: 10.1186/s12957-015-0538-1. World J Surg Oncol. 2015. PMID: 25890325 Free PMC article. Review.
-
Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.Clin Breast Cancer. 2015 Oct;15(5):307-12. doi: 10.1016/j.clbc.2015.03.010. Epub 2015 Mar 25. Clin Breast Cancer. 2015. PMID: 25922284 Review.
Cited by
-
Case Report: 68Ga-FAPI PET/CT, a more advantageous detection mean of gastric, peritoneal, and ovarian metastases from breast cancer.Front Oncol. 2022 Oct 26;12:1013066. doi: 10.3389/fonc.2022.1013066. eCollection 2022. Front Oncol. 2022. PMID: 36387126 Free PMC article.
-
A case of multiple bone metastases during the course of non-invasive bladder and prostate cancer.IJU Case Rep. 2025 Feb 2;8(2):158-161. doi: 10.1002/iju5.12836. eCollection 2025 Mar. IJU Case Rep. 2025. PMID: 40034910 Free PMC article.
-
Multiple roles and regulatory mechanisms of the transcription factor HNF4 in the intestine.Front Endocrinol (Lausanne). 2023 Aug 10;14:1232569. doi: 10.3389/fendo.2023.1232569. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37635981 Free PMC article. Review.
-
HNF4A Regulates the Proliferation and Tumor Formation of Cervical Cancer Cells through the Wnt/β-Catenin Pathway.Oxid Med Cell Longev. 2022 Jan 28;2022:8168988. doi: 10.1155/2022/8168988. eCollection 2022. Oxid Med Cell Longev. 2022. PMID: 35132353 Free PMC article.
-
LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway.J Cell Mol Med. 2021 Sep;25(17):8174-8186. doi: 10.1111/jcmm.16657. Epub 2021 Jul 26. J Cell Mol Med. 2021. PMID: 34309216 Free PMC article.
References
-
- Goldhirsch A, Winer EP, Coates AS, Gelber RD, Piccart-Gebhart M, Thürlimann B, Senn HJ. Panel members. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol. 2013;24:2206–2223. doi: 10.1093/annonc/mdt303. - DOI - PMC - PubMed
-
- Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO/IARC Classification of Tumours of the breast 4th. Lyon: IARC Press; 2012.
-
- Pectasides D, Psyrri A, Pliarchopoulou K, Floros T, Papaxoinis G, Skondra M, Papatsibas G, Macheras A, Athanasas G, Arapantoni-Datioti P, Economopoulos T. Gastric metastases originating from breast cancer: report of 8 cases and review of the literature. Anticancer Res. 2009;29:4759–4763. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials